Home › Lab Tests › Flurocent Treponemal Antibody(FTA) Test
₹1,530₹2,000 24% off
The Fluorescent Treponemal Antibody (FTA-ABS) test is a blood test that looks for antibodies against Treponema pallidum, the bacterium that causes syphilis. It is a specific test that is mainly used to confirm a positive screening test such as VDRL or RPR. Doctors use it to establish whether a person has ever been infected with syphilis, including in pregnancy and in late or hidden stages of the disease.
No fasting required. The sample can be given at any time of day.
It is done to confirm whether a positive screening test for syphilis is truly due to syphilis, because screening tests such as VDRL and RPR can be positive for other reasons. It is also used when syphilis is strongly suspected but the screening test is negative.
People with a positive VDRL or RPR result, those with a painless sore on the genitals, a skin rash on the palms and soles or other signs of syphilis, partners of an infected person and pregnant women whose screening test is positive. Your doctor will advise if it is needed.
No fasting or special preparation is needed, and the sample can be given at any time of day. Tell your doctor about any earlier syphilis infection or treatment and about any autoimmune condition, as these affect how the result is read.
A small blood sample is drawn from a vein in your arm, which takes a few minutes. You can return to normal activities straight away. In the laboratory the sample is examined under a special microscope for antibodies that glow when they attach to the syphilis bacterium.
Usually not. In most people this test stays positive for life, even after the infection has been treated and cured. For this reason it cannot be used to check whether treatment has worked; doctors follow the VDRL or RPR titre for that.
A positive result means you have been infected with syphilis at some time, either now or in the past. It cannot tell a current infection from a treated one on its own. Your doctor will decide on treatment after looking at your screening test titre, history of treatment and symptoms.